Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials
Titel:
Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials
Auteur:
Hilton, J. F. Bouganim, N. Dong, B. Chapman, J. W. Arnaout, A. O’Malley, F. Gelmon, K. A. Yerushalmi, R. Levine, M. N. Bramwell, V. H. C. Whelan, T. J. Pritchard, K. I. Shepherd, L. E. Clemons, M.